Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Mitsui Chemicals, Inc.
  6. News
  7. Summary
    4183   JP3888300005

MITSUI CHEMICALS, INC.

(4183)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Mitsui Chemicals : Launched New Lens Material "UV+420cutTM"

10/26/2014 | 09:01pm EDT

Mitsui Chemicals, Inc. (TOKYO:4183) (President & CEO: Tsutomu Tannowa) announced that it commenced sales of a new breakthrough ophthalmic lens material that helps protect eyes from not only ultraviolet (10-400nm) light rays but also 400nm-420nm wavelength light.

Our eyes are constantly damaged by sunlight exposure and therefore it is important to protect eyes from UV exposure. Recent studies have shown, however, that shorter wavelength light from 400nm-420nm also damages the retina, which is the most vulnerable tissue of the eye, and this can be one of the factors which accelerates the development of Age-related Macular Degeneration (AMD) and cataracts. Although many conventional sunglasses, in addition to protecting from UV rays, provide protection from shorter wavelength light, general vision correction lenses do not. Mitsui Chemicals’ newly debuted lens material, "UV+420cutTM", helps protect eyes from damaging short wavelength light.

This technology is used in the new "LUTINA®" lenses of Tokai Optical Co., Ltd.

Mitsui Chemicals provides performance-driven lens materials ranging from high to low refractive indices as well as optimum coating materials for lenses to meet diversifying global market needs. It will continue to develop groundbreaking, value-added vision care materials.


ę Business Wire 2014
All news about MITSUI CHEMICALS, INC.
09/10MITSUI CHEMICALS : Agro to Acquire Meiji Seika Pharma's Agrochemicals Business
PU
09/03Global Ichiba Corp. announced that it has received funding from Mitsui Chemicals, Inc.
CI
09/02FINANCIAL DATA 2020(PDF : 2.2mb)
PU
08/27Mitsui Chemicals, Inc. authorizes a Buyback Plan.
CI
08/27Mitsui Chemicals, Inc. announces an Equity Buyback for 3,500,000 shares, representing 1..
CI
08/26MITSUI CHEMICALS : Launches Nutanix Cloud Platform-Based “Next-Generation Factory DX..
PU
08/17MITSUI CHEMICALS : IBM Japan, and Nomura Research Institute Agree to Establish a Consortiu..
PU
08/05SUMMARY OF CONSOLIDATED FINANCIAL RE : 541.5kb)
PU
08/05FINANCIAL SUMMARY - RESULTS FOR FIRS : 373.9kb)
PU
07/14MITSUI CHEMICALS : 2022 Mitsui Chemicals Catalysis Science Awards
PU
More news
Financials
Sales 2022 1 521 B 13 730 M 13 730 M
Net income 2022 111 B 1 003 M 1 003 M
Net Debt 2022 324 B 2 930 M 2 930 M
P/E ratio 2022 7,03x
Yield 2022 2,81%
Capitalization 773 B 6 980 M 6 977 M
EV / Sales 2022 0,72x
EV / Sales 2023 0,71x
Nbr of Employees 18 051
Free-Float 90,1%
Chart MITSUI CHEMICALS, INC.
Duration : Period :
Mitsui Chemicals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MITSUI CHEMICALS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 3 945,00 JPY
Average target price 4 344,00 JPY
Spread / Average Target 10,1%
EPS Revisions
Managers and Directors
Osamu Hashimoto Executive President, CEO & Representative Director
Tsutomu Tannowa Chairman
Hideki Matsuo Representative Director & Chief Technology Officer
Yukiko Kuroda Independent Outside Director
Hajime Bada Independent Outside Director
Sector and Competitors